Treace Medical Concepts Inc (TMCI)

Currency in USD
7.42
-0.02(-0.27%)
Closed·
7.420.00(0.00%)
·
TMCI Scorecard
Full Analysis
Analysts do not anticipate the company will be profitable this year
TMCI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.307.49
52 wk Range
4.5410.79
Key Statistics
Prev. Close
7.44
Open
7.4
Day's Range
7.3-7.49
52 wk Range
4.54-10.79
Volume
355.17K
Average Volume (3m)
339.82K
1-Year Change
18.47%
Book Value / Share
1.55
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TMCI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.35
Upside
+12.53%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy

Treace Medical Concepts Inc Company Profile

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Treace Medical Concepts Inc Earnings Call Summary for Q2/2025

  • Treace Medical Q2 2025: EPS -$0.28 (beat), revenue $47.39M (beat). Stock up 3.84% after-hours to $5.68.
  • Net loss improved 18% YoY. Adjusted EBITDA loss reduced 58%. Revenue grew 7% YoY despite slight gross margin decline.
  • Full-year 2025 revenue guidance: $224M-$230M (7-10% growth). Expects breakeven adjusted EBITDA and Q4 revenue boost.
  • CEO highlights strategic hires and upcoming Lapoplasty Lightning launch as key growth drivers.
  • Challenges: Low market penetration (2.8%), gross margin pressure, and product launch risks amid economic uncertainties.
Last Updated: 08/08/2025, 10:48
Read Full Transcript

Compare TMCI to Peers and Sector

Metrics to compare
TMCI
Peers
Sector
Relationship
P/E Ratio
−9.6x−4.6x−0.5x
PEG Ratio
−0.41−0.100.00
Price/Book
4.8x3.5x2.6x
Price / LTM Sales
2.2x3.7x3.3x
Upside (Analyst Target)
−1.6%52.1%38.7%
Fair Value Upside
Unlock0.1%5.0%Unlock

Analyst Ratings

2 Buy
4 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 8.35
(+12.53% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
-0.28 / -0.29
Revenue / Forecast
47.39M / 47.08M
EPS Revisions
Last 90 days

TMCI Income Statement

People Also Watch

18.08
SRPT
-0.99%
14.84
OFIX
+2.27%
10.01
ANGO
+2.25%
30.560
SMLR
-0.75%
11.45
VREX
+1.51%

FAQ

What Stock Exchange Does Treace Medical Concepts Trade On?

Treace Medical Concepts is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Treace Medical Concepts?

The stock symbol for Treace Medical Concepts is "TMCI."

What Is the Treace Medical Concepts Market Cap?

As of today, Treace Medical Concepts market cap is 466.22M.

What Is Treace Medical Concepts's Earnings Per Share (TTM)?

The Treace Medical Concepts EPS (TTM) is -0.79.

When Is the Next Treace Medical Concepts Earnings Date?

Treace Medical Concepts will release its next earnings report on 10 Nov 2025.

From a Technical Analysis Perspective, Is TMCI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Treace Medical Concepts Stock Split?

Treace Medical Concepts has split 0 times.

How Many Employees Does Treace Medical Concepts Have?

Treace Medical Concepts has 477 employees.

What is the current trading status of Treace Medical Concepts (TMCI)?

As of 27 Aug 2025, Treace Medical Concepts (TMCI) is trading at a price of 7.42, with a previous close of 7.44. The stock has fluctuated within a day range of 7.30 to 7.49, while its 52-week range spans from 4.54 to 10.79.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.